Merit’s Embosphere microspheres receive expanded indication to control haemorrhaging in the peripheral vasculature

Embosphere microspheres (Merit Medical)

The FDA has cleared an expanded indication of Embosphere microspheres (Merit Medical) for the embolization of blood vessels to occlude blood flow in the peripheral vasculature to control bleeding or haemorrhaging.

The Embosphere microspheres are the first spherical embolic devices to be cleared for this use.

According to Merit Medical, Embosphere microspheres have now received more indications for use than any other spherical embolic on the market.

With this approval, Embosphere microspheres are now indicated for use in embolization of arteriovenous malformations, hypervascular tumours, symptomatic uterine fibroids, prostatic arteries for the relief of symptoms related to benign prostatic hyperplasia, and for controlling bleeding or haemorrhaging in the peripheral vasculature.



Please enter your comment!
Please enter your name here